This special panel presentation features three leaders in the space:
Tara Denham, supervisor of vestibular physical therapy, is a leading expert in the field of vestibular therapy and founder of the Vestibular Physical Therapy Center at Rusk. As an American Physical Therapy Association certified vestibular clinician, she lectures extensively to a wide range of audiences. Eva Mihovich has served as a Senior Psychologist at Rusk Rehabilitation, NYU Langone Health Centers for over 20 years, and is a clinical instructor at the NYU School of Medicine. She currently coordinates Psychological Services at the Vestibular Rehabilitation Department at Rusk Rehabilitation. Her Ph.D. is from New York University. Dr. Jennifer Fay is a board-certified clinical specialist in Neurologic Physical Therapy through the American Board of Physical Therapy Specialties and is a clinical instructor in the Department of Physical Medicine and Rehabilitation in the NYU School of Medicine. Artmis Youssefnia is Senior Level II in the vestibular therapy department at Rusk Institute: NYU Langone Health System. She has over 20 years of experience working with patients with pulmonary disease and vestibular dysfunction and does extensive community outreach/education. She also is adjunct professor for Cardiovascular Pulmonary Examination at NYU Physical Therapy school. This is the second of a two-part series. In this episode, the panel covers: whether any patients report out-of-body experiences associated with 3PD, evaluation techniques used in developing treatment plans for patients; dominant treatment approaches; roles played by gait training and gaze stabilization; status of clinical practice guidelines and evidence-based treatments; research gaps where more studies may be necessary; factors that may characterize patients, such as fear of the future or threats to self-image that possibly could detract from the success of rehabilitation kinds of interventions; major components of a cognitive-behavioral approach to treating 3PD; whether plateaus ever occur where further treatment is not associated with additional improvements; and current research and proposed studies on the drawing board aimed at shedding additional light on 3PD.